Recruiting adults 18-75 years of age with a diagnosis of plaque psoriasis for a clinical trial. Eligible candidates must have a diagnosis of moderate-to-severe plaque psoriasis covering 10% or more of their body surface area (BSA) for the past 6 months or more, but not other forms of psoriasis. A body mass index (BMI) of 18.0 – 35.0 kg/m2 is also required. Participants who have not received systemic treatment for plaque psoriasis, or who have received at least one conventional anti-psoriasis treatment, may be eligible to participate.
Participants will receive investigational oral treatment (active study drug) or placebo during the treatment period. Study treatment and study-related assessments will be provided at no cost. Reimbursement for study-related expenses may be provided.
Study participation will last about 4 months and involve about 8 visits to the study centre.
The following information is from ClinicalTrials.gov
Last Update Posted: March 01, 2023
Ages Eligible for Study:
18-75 Years
Sexes Eligible for Study:
Male and Female
Terms and Conditions – ClinicalTrials.gov
Purpose of ClinicalTrials.gov Database. The U.S. National Institutes of Health, Department of Health and Human Services, through its National Library of Medicine, has developed ClinicalTrials.gov to provide patients, family members, and members of the public current information about clinical research studies.
Los Angeles - Metropolis Dermatology
Similar Trials
No Similar Trials Found
register now
REGISTER NOW